SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Drug repurposing in oncology—patient and health systems opportunities
1 references·3 citing·13 second hop
Drug repurposing in oncology—patient and health systems opportunities (2015)Drug repurposing in oncology—patient and …OECD Information Technology Outlook 2008 (2008)OECD Information Technology O…Repurposing drugs in oncology: From candidate selection to clinical adoption (2020)Repurposing drugs in oncology…On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients (2020)On-Label or Off-Label? Overco…Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics (2017)Giving Drugs a Second Chance:…New uses for old drugs (2007)Lessons from 60 years of pharmaceutical innovation (2009)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers (2021)Drug repurposing: a systematic review on root causes, barriers and facilitators (2022)ecancermedicalscience (2016)Entrez Direct: E-utilities on the UNIX Command Line (2016)Repurposing Drugs in Oncology: Next Steps (2017)Challenges and opportunities of drug repositioning (2013)Overcoming the legal and regulatory barriers to drug repurposing (2018)Innovation, employment and skills in services. Firm and sectoral evidence (2003)Globalisation, knowledge and the myth of the magnet economy (2006)The relationship between technology, innovation, and firm performance—Empirical evidence from e-business in Europe (2008)
this work references cited by second hop

References

  • 2008OECD Information Technology Outlook 200880 cited

Cited by

  • 2017Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics281 cited
  • 2020On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients79 cited
  • 2020Repurposing drugs in oncology: From candidate selection to clinical adoption69 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work